PKD1 and breast cancer: However, LPA treatment elevated PKD-1 levels in the BC tissues to an even greater extent and increased the percentage of the PKD-1+ megakaryocyte (MC) and/or polykaryocyte (PC) (Supplementary Fig. 5).